Tags

Type your tag names separated by a space and hit enter

[Hypersalivation - Update of the S2k guideline (AWMF) in short form].
Laryngorhinootologie 2019; 98(6):388-397L

Abstract

Hypersalivation describes a relatively excessive salivary flow, which wets the patient himself and his surroundings. It may result because of insufficient oro-motor function, dysphagia, decreased central control and coordination. This update presents recent changes and innovation in the treatment of hypersalivation.Multidisciplinary diagnostic and treatment evaluation is recommended already at early stage and focus on dysphagia, saliva aspiration, and oro-motor deficiencies. Clinical screening tools and diagnostics such as fiberoptic endoscopic evaluation of swallowing generate important data on therapy selection and control. Many cases profit from swallowing therapy programmes in order to activate compensation mechanisms as long compliances is given. In children with hypotonic oral muscles, oral stimulation plates can induce a relevant symptom release because of the improved lip closure. The pharmacologic treatment improved for pediatric cases as glycopyrrolate fluid solution (Sialanar®) is now indicated for hypersalivation within the E. U. The injection of botulinum toxin into the salivary glands has shown safe and effective results with long lasting saliva reduction. Here, a phase III trial is completed for Incobotulinum toxin A and, in the U. S., is indicated for the treatment of adult patients with chronic hypersalivation. Surgical treatment should be reserved for isolated cases. External radiation is judged as a safe and effective therapy when using modern 3 D techniques to minimize tissue damage. Therapy effects and symptom severity has to be followed, especially in cases with underlying neurodegenerative disease.

Authors+Show Affiliations

Universität zu Lübeck HNO-Klinik.Universitätsmedizin Göttingen, HNO-Klinik.Universitätsklinikum Münster Klinik für Psychiatrie und Psychotherapie.Wissenschaftliches Institut für angewandte HNO-Heilkunde HNO-Praxis Bad Bramstedt.Curavid Praxis für Strahlentherapie Radiologie.Evangelische Hochschule Berlin Pflege- und Gesundheitswissenschaften.Phoniatrie Universitätsklinikum Schleswig-Holstein.Gemeinschaftspraxis Am Rosenplatz.Dr. von Haunersches Kinderspital Ludwig-Maximilians-Universität München Pädiatrische Neurologie und Entwicklungsneurologie.Ludwig-Maximilians-Universität München, Medizinische Fakultät, Institut für Phonetik und Sprachverarbeitung.Klinikum der Universität München, Klinik für Hals-, Nasen- und Ohrenheilkunde.Parkinson-Klinik Ortenau GmbH & Co. KG.HELIOS Fachklinik Schleswig, Psychiatry and Psychosomatik Medicine.Praxis für Neurologie, Psychiatrie, Psychotherapie und Nervenheilkunde.Universitätsklinikum der FSU Jena HNO.Universität zu Lübeck, Institut für Neurogenetik.Georg-August-Universität Göttingen, Universitätsmedizin Klinik für Hals-Nasen-Ohrenheilkunde.Friedrich-Alexander-Universität Erlangen-Nürnberg, Medizinische Fakultät, Studiengang B. Sc. Logopädie.Evangelisches Krankenhaus Oldenburg Klinik für Neurologische Intensivmedizin und Frührehabilitation.Uniklinik Köln Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, Kopf- und Hals-Chirurgie Köln.Universität zu Lübeck, Klinik für Kiefer- und Gesichtschirurgie.Medizinische Hochschule Hannover, Klinik für Psychiatrie, Sozialpsychiatrie und Psychotherapie.

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

31167292

Citation

Steffen, Armin, et al. "[Hypersalivation - Update of the S2k Guideline (AWMF) in Short Form]." Laryngo- Rhino- Otologie, vol. 98, no. 6, 2019, pp. 388-397.
Steffen A, Jost W, Bäumer T, et al. [Hypersalivation - Update of the S2k guideline (AWMF) in short form]. Laryngorhinootologie. 2019;98(6):388-397.
Steffen, A., Jost, W., Bäumer, T., Beutner, D., Degenkolb-Weyers, S., Groβ, M., ... Guntinas-Lichius, O. (2019). [Hypersalivation - Update of the S2k guideline (AWMF) in short form]. Laryngo- Rhino- Otologie, 98(6), pp. 388-397. doi:10.1055/a-0874-2406.
Steffen A, et al. [Hypersalivation - Update of the S2k Guideline (AWMF) in Short Form]. Laryngorhinootologie. 2019;98(6):388-397. PubMed PMID: 31167292.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Hypersalivation - Update of the S2k guideline (AWMF) in short form]. AU - Steffen,Armin, AU - Jost,Wolfgang, AU - Bäumer,Tobias, AU - Beutner,Dirk, AU - Degenkolb-Weyers,Sabine, AU - Groβ,Martin, AU - Grosheva,Maria, AU - Hakim,Samer, AU - Kahl,Kai G, AU - Laskawi,Rainer, AU - Lencer,Rebekka, AU - Löhler,Jan, AU - Meyners,Thekla, AU - Rohrbach-Volland,Saskia, AU - Schönweiler,Rainer, AU - Schröder,Sara-Christina, AU - Schröder,Sebastian, AU - Schröter-Morasch,Heidrun, AU - Schuster,Maria, AU - Steinlechner,Susanne, AU - Urban,Roland, AU - Guntinas-Lichius,Orlando, Y1 - 2019/06/05/ PY - 2019/6/6/entrez PY - 2019/6/6/pubmed PY - 2019/6/6/medline SP - 388 EP - 397 JF - Laryngo- rhino- otologie JO - Laryngorhinootologie VL - 98 IS - 6 N2 - Hypersalivation describes a relatively excessive salivary flow, which wets the patient himself and his surroundings. It may result because of insufficient oro-motor function, dysphagia, decreased central control and coordination. This update presents recent changes and innovation in the treatment of hypersalivation.Multidisciplinary diagnostic and treatment evaluation is recommended already at early stage and focus on dysphagia, saliva aspiration, and oro-motor deficiencies. Clinical screening tools and diagnostics such as fiberoptic endoscopic evaluation of swallowing generate important data on therapy selection and control. Many cases profit from swallowing therapy programmes in order to activate compensation mechanisms as long compliances is given. In children with hypotonic oral muscles, oral stimulation plates can induce a relevant symptom release because of the improved lip closure. The pharmacologic treatment improved for pediatric cases as glycopyrrolate fluid solution (Sialanar®) is now indicated for hypersalivation within the E. U. The injection of botulinum toxin into the salivary glands has shown safe and effective results with long lasting saliva reduction. Here, a phase III trial is completed for Incobotulinum toxin A and, in the U. S., is indicated for the treatment of adult patients with chronic hypersalivation. Surgical treatment should be reserved for isolated cases. External radiation is judged as a safe and effective therapy when using modern 3 D techniques to minimize tissue damage. Therapy effects and symptom severity has to be followed, especially in cases with underlying neurodegenerative disease. SN - 1438-8685 UR - https://www.unboundmedicine.com/medline/citation/31167292/[Hypersalivation_-_Update_of_the_S2k_guideline_(AWMF)_in_short_form] L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/a-0874-2406 DB - PRIME DP - Unbound Medicine ER -